Drug Price Trends for SM ASPIRIN

Average Pharmacy Cost for SM ASPIRIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
SM ASPIRIN EC 325 MG TABLET	70677-0071-01	0.02237	EACH	2025-03-19
SM ASPIRIN EC 81 MG TABLET	70677-0163-01	0.01553	EACH	2025-03-19
SM ASPIRIN EC 81 MG TABLET	49348-0981-15	0.01553	EACH	2025-03-19

Global Aspirin Market Analysis and Price Projections

Market Overview

The global aspirin market is a robust and evolving sector, driven by various factors including the increasing incidence of chronic diseases, rising healthcare expenditures, and the expanding pharmaceutical industry.

Current Market Size and Forecast

As of 2022, the global aspirin market was valued at approximately USD 2,356.55 million. It is projected to grow to USD 2,917.59 million by 2030, with a compound annual growth rate (CAGR) of about 2.70% between 2023 and 2030[1].

Key Drivers of Market Growth

Increasing Incidence of Chronic Diseases

The rising prevalence of chronic conditions such as arthritis, pain, inflammation, renal disorders, cardiovascular diseases, and brain strokes is a significant driver of the aspirin market. These conditions necessitate the use of aspirin for pain management and prevention of further complications[3].

Growing Demand for Basic Medical Care

The increasing number of people contracting common contagious diseases like flu and cold, particularly in densely populated areas, contributes to the demand for aspirin. Adults are at risk of contracting colds around 2 to 3 times a year, and this rate is even higher in young children and infants[1].

Expansion of Pharmaceutical Industry

The robust pharmaceutical industry, especially in regions like China and India, plays a crucial role in the growth of the aspirin market. These countries are leaders in the production of Active Pharmaceutical Ingredients (APIs) and cater to the needs of other drug manufacturers globally[1].

Regional Market Analysis

Asia-Pacific Region

The Asia-Pacific region is expected to witness the highest growth in the aspirin market, driven by the presence of a robust pharmaceutical industry in countries like China and India. The large population base in these regions results in higher sales of basic medicines such as aspirin. Additionally, the rapid expansion of pharmacies providing over-the-counter (OTC) medicines, including aspirin, further propels market growth[1].

North America

In the United States, the aspirin market is driven by the increasing need to manage chronic pain, particularly among adults who spend extended periods sitting. According to the Centers for Disease Control and Prevention, a significant percentage of U.S. adults suffer from chronic pain, which is a key driving factor for the demand for aspirin drugs in this region[3].

India

India's aspirin market is set to exhibit a CAGR of 3.4% through 2034, driven by substantial financing and the launch of healthcare programs such as Pradhan Mantri Jan Arogya Yojana and Ayushman Bharat. These programs offer accessible healthcare facilities and reimbursement options, boosting product demand[3].

Distribution Channels

Online and Offline Sales

The market is segmented into online and offline sales channels. While offline channels hold a significant market share, online sales channels are the fastest-growing segment, fueled by increasing internet penetration worldwide. During the COVID-19 pandemic, online sales of essential items, including aspirin, saw a significant surge as consumers preferred online retailing over visiting physical stores[4].

Challenges and Restraints

Associated Side Effects

The increasing awareness of side effects associated with aspirin intake, such as gastrointestinal issues and bleeding risks, is likely to restrict market growth. Additionally, the gradual increase in aspirin tolerance and patent expiry of certain aspirin formulations pose challenges to the market[1].

Competition from Alternative Medications

The presence of alternative pain relief medications and the growing preference for safer, more targeted therapies could also impact the demand for aspirin[1].

Key Market Players

The global aspirin market is led by several prominent players, including:

• Bayer AG
• Bal Pharma Limited
• Globalimporter Inc.
• JQC (Huayin) Pharmaceutical Co., Ltd.
• Cardinal Health
• Par Pharmaceutical
• Perrigo Company plc.
• Nanjing Pharmaceutical Factory Co., Ltd.
• Trumac Healthcare
• Globela Pharma Pvt Ltd
• LNK International Inc.[1].

Price Projections and Market Value

Global Market Value

By 2034, the global aspirin drug market is expected to reach a valuation of US$ 4,236.9 million, growing at a CAGR of 3.8% from 2024 to 2034[3].

Regional Market Value

In the United States, the aspirin market is expected to seize a 25.7% global market share in 2024, driven by the increasing need for aspirin to manage chronic pain[3].

Illustrative Statistics

• Market Size in 2022: USD 2,356.55 million[1]
• Forecasted Market Size in 2030: USD 2,917.59 million[1]
• CAGR (2023-2030): 2.70%[1]
• Global Market Value by 2034: US$ 4,236.9 million[3]
• CAGR (2024-2034): 3.8%[3]
• Prevalence of Chronic Pain in the U.S.: 4% (50.0 million) suffering from chronic pain and 8.0% (19.6 million) from high-impact chronic pain[3].

Expert Insights and Quotes

"The growing API industry will further contribute to propelling the market growth of acetylsalicylic acid as an active ingredient in drug formulations." - Research and Markets[4].

Highlight and Citation

"The global aspirin market is expected to witness the highest growth in Asia-Pacific driven by the presence of a robust pharmaceutical industry, especially in regions such as China and India." - Zion Market Research[1].

Key Takeaways

• The global aspirin market is projected to grow at a CAGR of 2.70% from 2023 to 2030.
• The market is driven by the increasing incidence of chronic diseases and the expansion of the pharmaceutical industry.
• Asia-Pacific, particularly China and India, will witness the highest growth due to their robust pharmaceutical industries.
• Online sales channels are expected to be the fastest-growing segment.
• Side effects and the gradual increase in aspirin tolerance are potential restraints on market growth.

Frequently Asked Questions (FAQs)

1. What is the current market size of the global aspirin market? The global aspirin market was valued at approximately USD 2,356.55 million in 2022[1].

2. What is the forecasted growth rate of the global aspirin market? The global aspirin market is expected to grow at a CAGR of 2.70% from 2023 to 2030[1].

3. Which region is expected to witness the highest growth in the aspirin market? The Asia-Pacific region, particularly China and India, is expected to witness the highest growth due to the presence of a robust pharmaceutical industry[1].

4. What are the key drivers of the aspirin market? Key drivers include the increasing incidence of chronic diseases, growing demand for basic medical care, and the expansion of the pharmaceutical industry[1][3].

5. What are the potential restraints on the aspirin market? Potential restraints include associated side effects, the gradual increase in aspirin tolerance, and patent expiry of certain aspirin formulations[1].

Cited Sources:

1. Zion Market Research - Aspirin Market Size, Share, Value and Forecast 2030
2. CoinCodex - ASPIRIN - Price Prediction 2024, 2025–2030
3. Future Market Insights - Aspirin Drug Market Size, Share & Forecast to 2034
4. Research and Markets - Aspirin Market - Forecasts from 2022 to 2027